Kenkichi Nozaki
Neurology · Birmingham, ALNPI 1225246184
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by UCB, Inc. at 31.8% of the total. That places this record below the midpoint for neurology clinicians in AL, where the typical reported total is $2,219.
Across 11 payments — averaging $116.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$406
- AstraZeneca$173
- Cadwell Industries, Inc$170
- Alnylam Pharmaceuticals Inc.$125
- CSL Behring$124
- Argenx US, Inc.$109
- plus $172 from 2 others
Across 2 payments — averaging $13,439 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Catalyst Pharmaceuticals, Inc.$27K
What the payments were for
- Food & beverage$1,20394%
- Education$776%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 3 | $406 |
| AstraZeneca | 2 | $173 |
| Cadwell Industries, Inc | 1 | $170 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| CSL Behring | 1 | $124 |
| Argenx US, Inc. | 1 | $109 |
| Biogen | 1 | $95 |
| Johnson & Johnson | 1 | $77 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,280 in reported general payments places this provider in the 45th percentile of 255 neurology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 65 | $1,279,651 |
| FirdapseAmifampridine Phosphate | 12 | $515,210 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 15 | $158,497 |
| Pyridostigmine Bromide | 87 | $6,655 |
| Mycophenolate Mofetil | 97 | $6,328 |
| Pyridostigmine Bromide ErPyridostigmine Bromide | 21 | $6,211 |
| Azathioprine | 27 | $1,648 |
| Prednisone | 159 | $863 |
| Methylprednisolone Sodium SuccMethylprednisolone Sod Succ | 26 | $624 |
| Duloxetine Hcl | 19 | $474 |
| Gabapentin | 23 | $376 |
| Sodium Chloride0.9 % Sodium Chloride | 40 | $264 |
| Pregabalin | 11 | $230 |
| Diphenhydramine Hcl | 15 | $57 |
| Ondansetron HclOndansetron Hcl/Pf | 13 | $50 |
Paid to pharmacies, not to this prescriber.
Other neurology in Birmingham
- Diane CounceBirmingham$895K
- Emily RiserBirmingham$231K
- Wesley KingBirmingham$167K
- Jerzy SzaflarskiBirmingham$164K
- Victor SungBirmingham$138K
- Raymond FaughtBirmingham$99K
- David GeldmacherBirmingham$99K
- David StandaertBirmingham$82K
- Richard DiethelmBirmingham$65K
- Mina LobbousBirmingham$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.